Drugs that show promising results will be submitted for Cancer Drug Fund assessment and NHS approval, providing new treatment options for patients with difficult-to-treat cancers. Sometimes ...

However, 19 out of 20 cancer patients currently cannot enroll in clinical trials because of rigid eligibility criteria, and genomic data used for clinical studies are still predominantly derived ...

In a bold move that underscores its dedication to advancing cancer prevention and patient outcomes, Human Longevity is pledging up to $1 million for each qualified member diagnosed with late-stage ...

One of the country’s leading cancer research and treatment organizations ... research and programs that support the unique needs of patients and families, all of which will bring us closer ...